Home / Drug shortages / Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 10/12/2022.

Shortage Details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
57844-117-01
Dosage Form
Tablet
Presentation
Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)
Initial Posting
10/12/2022
Revised Date

FDA data resources